Outcome of Different Ablation Strategies In Persistent and Long-Standing Persistent Atrial Fibrillation
Completed · Phase 3
Conditions studied: Atrial Fibrillation
In brief
Specific Aim: This prospective randomized study aims to compare the impact of three different catheter ablation approaches on long-term procedure outcome in terms of arrhythmia recurrence in persistent (PeAF) and long-standing persistent atrial fibrillation (LSPAF) patients. The three strategies to be evaluated are 1) ablation at sources guided by FIRMap (using RhythmView™ Workstation from TOPERA), 2) ablation at sources guided by FIRMap + conventional pulmonary vein antrum isolation (PVAI) and 3) Extended PVAI plus ablation of non-PV triggers and complex fractionated atrial electrograms (CFAE).
Key facts
- Study ID
- NCT02533843
- Run by
- Texas Cardiac Arrhythmia Research Foundation
- People needed
- 120
- Starts
- 2014-04-01
- Expected to finish
- 2017-07-01
- Last updated by the study team
- 2018-04-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age: ≥ 18 years
- Patients presenting with persistent or long-standing persistent AF
- Undergoing first ablation procedure
- Ability to provide written informed consent
You may not qualify if…
- Reversible causes of atrial arrhythmia such as hyperthyroidism, pneumonia, pulmonary embolism, sarcoidosis and excessive alcohol consumption
- Prior ablation procedures
- Pregnancy
Where it is running
- Texas Cardiac Arrhythmia Institute, St. david's Medical Center — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.